Why is methylergonovine contraindicated in patients with chronic hypertension?

Prepare for the NCLEX OB Postpartum Exam with our interactive questions and detailed explanations. Enhance your understanding of postpartum care and increase your chances of passing. Start practicing today!

Multiple Choice

Why is methylergonovine contraindicated in patients with chronic hypertension?

Explanation:
The main idea is that methylergonovine acts as a uterotonic by causing strong uterine contractions and also constricts vascular smooth muscle. In chronic hypertension, this vasoconstriction can provoke a dangerous rise in blood pressure and vasospasm, increasing the risk of stroke, myocardial ischemia, and other complications. Because of these safety concerns, methylergonovine is avoided in patients with long-standing hypertension, even though it can be effective for controlling postpartum hemorrhage. Clinicians would opt for other uterotonics, like oxytocin or certain prostaglandin analogs, that have a safer profile in hypertensive patients.

The main idea is that methylergonovine acts as a uterotonic by causing strong uterine contractions and also constricts vascular smooth muscle. In chronic hypertension, this vasoconstriction can provoke a dangerous rise in blood pressure and vasospasm, increasing the risk of stroke, myocardial ischemia, and other complications. Because of these safety concerns, methylergonovine is avoided in patients with long-standing hypertension, even though it can be effective for controlling postpartum hemorrhage. Clinicians would opt for other uterotonics, like oxytocin or certain prostaglandin analogs, that have a safer profile in hypertensive patients.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy